Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis.
about
News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation.Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis.Can biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies?Prognosis and risk assessment in AL amyloidosis - There and back again.Pitfalls in conducting prospective trials in stage III cardiac amyloidosis - experience from the REVEAL study.
P2860
Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Clinical and prognostic signif ...... 13 antigens in AL amyloidosis.
@en
Clinical and prognostic signif ...... 13 antigens in AL amyloidosis.
@nl
type
label
Clinical and prognostic signif ...... 13 antigens in AL amyloidosis.
@en
Clinical and prognostic signif ...... 13 antigens in AL amyloidosis.
@nl
prefLabel
Clinical and prognostic signif ...... 13 antigens in AL amyloidosis.
@en
Clinical and prognostic signif ...... 13 antigens in AL amyloidosis.
@nl
P2093
P50
P1433
P1476
Clinical and prognostic signif ...... 13 antigens in AL amyloidosis.
@en
P2093
Anna Komitopoulou
Anna Tasidou
Chrysanthi Skevaki
Constantinos Pamboucas
Efstathios Manios
Elektra Papadopoulou
Erasmia Psimenou
Evangelos Eleutherakis-Papaiakovou
Evangelos Terpos
Harikleia Gakiopoulou
P304
P356
10.1182/BLOOD-2016-02-702696
P407
P577
2016-05-10T00:00:00Z